The deviations noted on the FDA-483, your written responses to those deviations, and issues from our subsequent review of the inspection report are discussed below.
Failure to maintain accurate, complete, and current records relating to your participation in an investigation [21 CFR 812.140(a)].
Responsibilities of clinical investigators include maintaining accurate, complete, and current records relating to the investigator’s participation in an investigation.